134 related articles for article (PubMed ID: 4859330)
1. Factor VII during warfarin treatment.
Howarth DJ; Brozović M; Stirling Y; Reed M
Scand J Haematol; 1974; 12(5):346-54. PubMed ID: 4859330
[No Abstract] [Full Text] [Related]
2. Warfarin therapy. 1.
Deykin D
N Engl J Med; 1970 Sep; 283(13):691-4. PubMed ID: 4916914
[No Abstract] [Full Text] [Related]
3. Studies on experimentally induced hypercoagulable state in rabbits.
Izak G; Galewsky K
Thromb Diath Haemorrh; 1966 Jul; 16(1):228-42. PubMed ID: 5989043
[No Abstract] [Full Text] [Related]
4. Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration.
Levanon M; Rimon S; Shani M; Ramot B; Goldberg E
Br J Haematol; 1972 Dec; 23(6):669-77. PubMed ID: 4675008
[No Abstract] [Full Text] [Related]
5. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
Zivelin A; Rao LV; Rapaport SI
J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
[TBL] [Abstract][Full Text] [Related]
6. [Vitamin A overdosage. II. Cytological and biochemical changes in blood from high doses of vitamin A with and without alpha-tocopherol treatment].
Soliman MK
Int J Vitam Nutr Res; 1972; 42(4):576-82. PubMed ID: 4644617
[No Abstract] [Full Text] [Related]
7. Antibody neutralization in hypoprothrombinaemic plasma.
Parkin JD; Madaras F; Castaldi PA
Haemostasis; 1972-1973; 1(5):253-60. PubMed ID: 4677582
[No Abstract] [Full Text] [Related]
8. Improved control of long-term anticoagulant therapy.
Eastham RD
Br Med J; 1968 May; 2(5601):337-40. PubMed ID: 5648973
[No Abstract] [Full Text] [Related]
9. [Effect of nitro-- derivatives of warfarin on blood coagulation].
Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
[No Abstract] [Full Text] [Related]
10. The effects of coumadin on the prothrombin (factor II) coagulation pathway in man: relationship between antigen and activity levels.
Lox CD; Maciulla GJ; Heine MW; Messiha FS; Corrigan JJ
Proc West Pharmacol Soc; 1978; 21():237-9. PubMed ID: 693503
[No Abstract] [Full Text] [Related]
11. The control of warfarin anticoagulation. A University of Minnesota medical conference.
Hammerschmidt DE
Minn Med; 1987 Oct; 70(10):585-8. PubMed ID: 3683354
[No Abstract] [Full Text] [Related]
12. [Behavior of blood coagulation factors under the effect of a new pyrazol derivative during prolonged anticoagulant therapy].
Wolf H
Arzneimittelforschung; 1970 Sep; 20(9):1252-8. PubMed ID: 4098759
[No Abstract] [Full Text] [Related]
13. Blood coagulation, fibrinolysis and platelet function in women aged 38, 46, 50, 54 and 60. The study of women in Gothenburg 1968-1969.
Korsan-Bengtsen K; Bengtsson C; Tibblin E
Acta Med Scand; 1973 Jun; 193(6):543-6. PubMed ID: 4721963
[No Abstract] [Full Text] [Related]
14. Study of blood coagulation in women treated with megestrol acetate implants.
Lira P; Rivera L; Díaz S; Croxatto HB
Contraception; 1975 Dec; 12(6):639-44. PubMed ID: 1204351
[No Abstract] [Full Text] [Related]
15. Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy.
Zacharski LR; Rosenstein R
Blood; 1979 Mar; 53(3):366-74. PubMed ID: 760859
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of long-term oral anticoagulant therapy and its laboratory assessment.
Eastham RD
J Clin Pathol; 1975 Mar; 28(3):198-201. PubMed ID: 1123447
[TBL] [Abstract][Full Text] [Related]
17. Basic mechanisms in blood coagulation.
Davie EW; Fujikawa K
Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463
[No Abstract] [Full Text] [Related]
18. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.
Holm J; Hillarp A; Erhardt L; Berntorp E
Thromb Res; 1999 Nov; 96(3):205-12. PubMed ID: 10588463
[TBL] [Abstract][Full Text] [Related]
19. Consumption of serum factors and prothrombin during intravascular clotting in rabbits.
Rapaport SI; Hjort PF; Patch MJ; Jeremic M
Scand J Haematol; 1966; 3(1):59-75. PubMed ID: 5914457
[No Abstract] [Full Text] [Related]
20. A COMPARISON OF BISHYDROXYCOUMARIN AND WARFARIN SODIUM IN TERMS OF COAGULATION FACTOR CHANGES AND BLEEDING COMPLICATIONS.
FREMONT RE; WIEDMAN M; LUBELL D
Am J Med Sci; 1963 Sep; 246():265-76. PubMed ID: 14063743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
